Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01193218 · COMPLETED
Trial details
- NCT number
- NCT01193218
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-06-01
- Enrollment
- 547
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.